obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with BMI=25 kg/m2 , who are overweight or obese, or who are obese after sleeve gastric surgery; 2. Patients understood the purpose of the trial, volunteered to participate in the trial and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Gastroscopy and surgical contraindications, including but not limited to: 1) Heart failure; 2) Persistent dyspnea; 3) Abscess of the posterior pharyngeal wall, severe spinal malformation or aortic aneurysm; 4) The body is too weak to tolerate endoscopy; 5) Acute stage of corrosive inflammation of the upper digestive tract or suspected perforation of the upper digestive tract; 6) A large number of ascites, severe abdominal distension or severe esophageal varices; 7) Abnormal blood coagulation function; 2. Patients receiving upper gastrointestinal anastomosis; 3. Tumors, active peptic ulcers and bleeding were found under endoscopy; 4. Patients with fundus hemorrhage at present; 5. Identify patients diagnosed with type 1 diabetes; 6. Patients with severe hepatic and renal dysfunction with creatinine concentration greater than 180 µmol/L; 7. Patients with intestinal obstruction or related history in the past year; 8. Patients with a history of systemic lupus erythematosus and scleroderma; 9. Pregnant women or patients trying to become pregnant; 10.Drug or alcohol addiction or uncontrollable mental illness; 11. Patients who have participated in clinical trials of other drugs or medical devices before enrollment and have not reached the end time limit;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight;Fasting Blood Glucose;Total weight loss; | — |
Secondary
| Measure | Time frame |
|---|---|
| 2 hours Postprandial Blood Glucose;Glycosylated Hemoglobin;Gastrointestinal Symptom Rating Scale; | — |
Countries
China
Contacts
China-Japan Friendship Hospital